Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Sell
40
KHNGY Quote, Financials, Valuation and Earnings
Last price:
$45.97
Seasonality move
:
2.4%
Day range:
$45.33 - $45.52
52-week range:
$39.53 - $62.83
Dividend yield:
4.85%
P/E ratio:
19.90x
P/S ratio:
0.93x
P/B ratio:
8.22x
Volume:
8.4K
Avg. volume:
43.3K
1-year change:
-15.52%
Market cap:
$26.9B
Revenue:
$28.2B
EPS (TTM):
$2.28
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Kuehne + Nagel International AG has -- downside to fair value with a price target of -- per share.
KHNGY vs. S&P 500
-
Over the past 5 trading days, Kuehne + Nagel International AG has overperformed the S&P 500 by 1.07% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Kuehne + Nagel International AG does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Kuehne + Nagel International AG has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Kuehne + Nagel International AG reported revenues of $7B.
Earnings Growth
-
Kuehne + Nagel International AG has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Kuehne + Nagel International AG reported earnings per share of $0.54.
Enterprise value:
26.3B
EV / Invested capital:
7.27x
Price / LTM sales:
0.93x
EV / EBIT:
13.64x
EV / Revenue:
0.91x
PEG ratio (5yr expected):
--
EV / Free cash flow:
15.97x
Price / Operating cash flow:
16.39x
Enterprise value / EBITDA:
9.11x
Gross Profit (TTM):
$10B
Return On Assets:
10.18%
Net Income Margin (TTM):
4.68%
Return On Equity:
39.49%
Return On Invested Capital:
36.14%
Operating Margin:
6.35%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $37.6B | $25.5B | $28.9B | $6.3B | $7B | |
| Gross Profit | $9.4B | $9.6B | $10B | $2.4B | $2.5B | |
| Operating Income | $3.4B | $1.9B | $1.9B | $430.2M | $446.9M | |
| EBITDA | $4.3B | $2.8B | $2.9B | $668.2M | $711.5M | |
| Diluted EPS | $4.04 | $2.36 | $2.28 | $0.53 | $0.54 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $7.1B | $11.4B | $10.1B | $7.3B | $7.1B | |
| Total Assets | $11.2B | $16.9B | $15.4B | $13.4B | $14.3B | |
| Current Liabilities | $6B | $9.6B | $7.5B | $6.2B | $7.7B | |
| Total Liabilities | $8.2B | $12.7B | $10.6B | $9.5B | $11B | |
| Total Equity | $3B | $4.2B | $4.8B | $3.9B | $3.3B | |
| Total Debt | $455.4M | $462.5M | $239.7M | $247.2M | $330.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $4B | $1.5B | $1.9B | $200.2M | $432.4M | |
| Cash From Investing | -$232.7M | -$540M | -$806.4M | -$296.3M | -$589.2M | |
| Cash From Financing | -$2.7B | -$3.3B | -$2.2B | -$203.7M | -$214.6M | |
| Free Cash Flow | $3.7B | $1.1B | $1.6B | $59.5M | $363.5M | |
KHNGY
Sector
Market Cap
$26.9B
$588.9M
Price % of 52-Week High
72.24%
72.6%
Dividend Yield
4.85%
0%
Shareholder Yield
4.9%
2.44%
1-Year Price Total Return
-15.52%
-8.43%
Beta (5-Year)
0.869
0.764
Dividend yield:
4.85%
Annualized payout:
$2.20
Payout ratio:
99.21%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$45.16
200-day SMA
Sell
Level
$50.37
Bollinger Bands (100)
Sell
Level
44.09 - 47.55
Chaikin Money Flow
Buy
Level
549.9K
20-day SMA
Buy
Level
$43.95
Relative Strength Index (RSI14)
Buy
Level
52.15
ADX Line
Buy
Level
14.56
Williams %R
Sell
Level
-16.5744
50-day SMA
Sell
Level
$45.97
MACD (12, 26)
Sell
Level
-0.01
25-day Aroon Oscillator
Sell
Level
-24
On Balance Volume
Neutral
Level
1.6M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.9873)
Buy
CA Score
(Annual)
Level (0.0479)
Buy
Beneish M-Score
(Annual)
Level (-2.4708)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (0.3678)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Kuehne+Nagel is a global transportation and logistics company founded in Switzerland in 1890. Following DSV's acquisition of DB Schenker, Kuehne+Nagel will be the second-largest sea freight forwarder globally and hold a minimum of the top three spots in air freight. Sea freight has traditionally constituted the largest part of the business, contributing 40% of group revenue in 2024. The company aims to become a more balanced, fully integrated freight forwarder while continually improving its end-to-end offering to its clients.
Stock Forecast FAQ
In the current month, KHNGY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The KHNGY average analyst price target in the past 3 months is --.
-
Where Will Kuehne + Nagel International AG Stock Be In 1 Year?
According to analysts, the consensus estimate is that Kuehne + Nagel International AG share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Kuehne + Nagel International AG?
Analysts are divided on their view about Kuehne + Nagel International AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Kuehne + Nagel International AG is a Sell and believe this share price will rise from its current level to --.
-
What Is Kuehne + Nagel International AG's Price Target?
The price target for Kuehne + Nagel International AG over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is KHNGY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Kuehne + Nagel International AG is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of KHNGY?
You can purchase shares of Kuehne + Nagel International AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Kuehne + Nagel International AG shares.
-
What Is The Kuehne + Nagel International AG Share Price Today?
Kuehne + Nagel International AG was last trading at $45.97 per share. This represents the most recent stock quote for Kuehne + Nagel International AG. Yesterday, Kuehne + Nagel International AG closed at $45.39 per share.
-
How To Buy Kuehne + Nagel International AG Stock Online?
In order to purchase Kuehne + Nagel International AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 5.48% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 1.82% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 3.3% over the past day.
